Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$1.83B |
| 2 |
Roblox
RBLX
|
+$1.63B |
| 3 |
BILL Holdings
BILL
|
+$1.46B |
| 4 |
Airbnb
ABNB
|
+$774M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$620M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$2.32B |
| 2 |
Spotify
SPOT
|
+$1.39B |
| 3 |
Okta
OKTA
|
+$1.24B |
| 4 |
Alibaba
BABA
|
+$1.16B |
| 5 |
Amazon
AMZN
|
+$1.05B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.4% |
| 2 | Healthcare | 9.82% |
| 3 | Financials | 9.22% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Communication Services | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5376
ARK Israel Innovative Technology ETF
IZRL
$144M
| $487K | ﹤0.01% |
16,655
+4,568
| +38% | +$138K |
|
5377
Park-Ohio Holdings
PKOH
$581M
| $487K | ﹤0.01% |
19,088
-3,707
| -16% | -$101K |
|
5378
Karat Packaging
KRT
$814M
| $486K | ﹤0.01% |
23,124
+6,334
| +38% | +$143K |
|
5379
QCR Holdings
QCRH
$1.71B
| $486K | ﹤0.01% |
9,438
+2,275
| +32% | +$112K |
|
5380
Luxfer Holdings
LXFR
$459M
| $485K | ﹤0.01% |
24,768
-1,607
| -6% | -$33.1K |
|
|
OGI
5381
Organigram Holdings
OGI
$136M
| $484K | ﹤0.01% |
52,494
-157,990
| -75% | -$1.62M |
|
5382
Aldeyra Therapeutics
ALDX
$92.3M
| $483K | ﹤0.01% |
55,120
-36,627
| -40% | -$336K |
|
5383
Invesco Bloomberg Analyst Rating Improvers ETF
UPGD
$121M
| $482K | ﹤0.01% |
8,032
+4,623
| +136% | +$276K |
|
5384
Flux Power
FLUX
$11.6M
| $480K | ﹤0.01% |
94,356
+77,775
| +469% | +$658K |
|
5385
Eagle Bancorp Montana
EBMT
$188M
| $479K | ﹤0.01% |
21,475
+1,389
| +7% | +$30.9K |
|
5386
Lexicon Pharmaceuticals
LXRX
$1.03B
| $479K | ﹤0.01% |
99,575
-35,186
| -26% | -$144K |
|
5387
INmune Bio
INMB
$49.2M
| $478K | ﹤0.01% |
24,631
+13,088
| +113% | +$253K |
|
5388
West Bancorporation
WTBA
$481M
| $478K | ﹤0.01% |
15,946
-756
| -5% | -$22.2K |
|
5389
Parke Bancorp
PKBK
$400M
| $477K | ﹤0.01% |
21,756
+1,005
| +5% | +$20.5K |
|
|
EARN
5390
Ellington Residential Mortgage REIT
EARN
$164M
| $476K | ﹤0.01% |
42,598
+1,352
| +3% | +$15.3K |
|
|
IRNT
5391
DELISTED
IronNet, Inc.
IRNT
| $476K | ﹤0.01% |
27,892
+22,905
| +459% | +$337K |
|
|
BLU
5392
DELISTED
BELLUS Health Inc.
BLU
| $476K | ﹤0.01% |
77,451
-179,405
| -70% | -$680K |
|
5393
iShares Core Dividend ETF
DIVB
$1.74B
| $475K | ﹤0.01% |
12,113
+12,095
| +67,194% | +$485K |
|
5394
iRadimed
IRMD
$1.17B
| $475K | ﹤0.01% |
14,152
+1,183
| +9% | +$40.2K |
|
|
STSA
5395
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $475K | ﹤0.01% |
102,090
-250,363
| -71% | -$1.33M |
|
5396
Vivani Medical
VANI
$115M
| $474K | ﹤0.01% |
49,602
+48,804
| +6,116% | +$550K |
|
5397
Southern First Bancshares
SFST
$601M
| $473K | ﹤0.01% |
8,862
-2,670
| -23% | -$135K |
|
|
ZIXI
5398
DELISTED
Zix Corporation
ZIXI
| $473K | ﹤0.01% |
66,865
-20,479
| -23% | -$148K |
|
5399
Minerva Neurosciences
NERV
$185M
| $471K | ﹤0.01% |
33,879
-45,262
| -57% | -$681K |
|
|
LEVL
5400
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
| $471K | ﹤0.01% |
16,024
-168
| -1% | -$4.63K |
|
Similar funds
Morgan Stanley's Q3 2021 Portfolio in Review
As of Q3 2021, Morgan Stanley held 8,301 positions worth $742B, down 2.1% from $758B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q3 2021 filing shows 450 new, 3,451 increased, 3,332 reduced and 228 closed positions. Its largest new stake was Ginkgo Bioworks: 281,861 shares worth $131M. The largest sale was Alphabet (Google) Class C, an estimated $2.32B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2021 buy was Ginkgo Bioworks: 281,861 shares worth $131M.
- Morgan Stanley added most to Coupang in Q3 2021, an estimated $1.83B increase.
- Morgan Stanley's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $2.32B.
- Morgan Stanley fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $441M.
- Morgan Stanley's ten largest holdings make up 15% of its $742B portfolio in Q3 2021.
- Morgan Stanley opened 450 new positions and closed 228 in Q3 2021.
- Morgan Stanley's portfolio value fell 2.1% quarter-over-quarter to $742B.
Based on Morgan Stanley's 13F filing for Q3 2021, filed 15 Nov 2021.